Exicure, Inc. - Common Stock (XCUR)
7.0400
+1.1500 (19.52%)
NASDAQ · Last Trade: Jun 30th, 6:47 PM EDT
U.S. stock futures up, focus on PRGS, XCUR, QMCO earnings. VERO jumps 43.6% after stake increase, IGC reports positive results. Check out Cramer's oil pick. Photo: Shutterstock.
Via Benzinga · June 30, 2025
Via Benzinga · June 27, 2025
Via Benzinga · April 17, 2025
Via Benzinga · March 18, 2025
Via Benzinga · March 13, 2025

Via Benzinga · February 7, 2025

GPCR USA is noted for its work in developing cutting-edge treatments, including Opdivo, a widely used autoimmune disease therapy generating about $10 billion in annual revenue.
Via Stocktwits · January 23, 2025

Via Benzinga · January 23, 2025

Via Benzinga · January 15, 2025

Via Benzinga · January 7, 2025

Via Benzinga · December 4, 2024

Via Benzinga · December 4, 2024

Via Benzinga · November 25, 2024

Via Benzinga · November 25, 2024

Via Benzinga · November 22, 2024

Via Benzinga · November 22, 2024

Via Benzinga · November 20, 2024

Via Benzinga · October 31, 2024

Via Benzinga · October 15, 2024

Via Benzinga · October 9, 2024

Via Benzinga · October 8, 2024

Via Benzinga · September 20, 2024